论文部分内容阅读
肺癌分非小细胞肺癌与小细胞肺癌,其中85%为非小细胞肺癌,65岁以上病人占非小细胞肺癌患者的50%。约30%的非小细胞肺癌和25%的小细胞肺癌患者在70岁以上,被称为老年肺癌。由于老年肺癌病人年龄大,体质相对弱,伴随慢性病多,包括心脏、肺、肾脏、肝脏、骨髓功能差,其治疗与年轻患者存在差异。早期非小细胞肺癌老年病人可以做手术者相对较少,不能接受手术的患者应考虑接受根治性放疗。对于应手术/放疗后辅助化疗的患者,要消除恐惧积极进行,医生会根据患者具体情况而选择治疗方案。如对于少数70～75岁体质及主要器官功能良好者会考虑给予标准含铂的双药联合化
Lung cancer is classified into non-small cell lung cancer and small cell lung cancer, of which 85% is non-small cell lung cancer, and patients over 65 years of age account for 50% of non-small cell lung cancer patients. About 30% of non-small cell lung cancer and 25% of patients with small cell lung cancer are over 70 years old and are called elderly lung cancer. Because elderly lung cancer patients are older and have relatively weak constitutions, and many chronic diseases, including poor function of the heart, lungs, kidneys, liver, and bone marrow, their treatment differs from young patients. There are relatively few elderly patients with early stage non-small cell lung cancer who can undergo surgery, and patients who cannot undergo surgery should be considered for radical radiotherapy. For patients undergoing adjuvant chemotherapy after surgery/radiotherapy, fear should be eliminated and the doctor will choose the treatment plan according to the specific conditions of the patient. For example, for a small number of people aged 70-75 years with good physical function and major organs, they may consider giving standard platinum-containing dual drug combinations.